-
Je něco špatně v tomto záznamu ?
A fatal combination: a thymidylate synthase inhibitor with DNA damaging activity
A. Ligasová, D. Strunin, D. Friedecký, T. Adam, K. Koberna,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, práce podpořená grantem
NLK
Directory of Open Access Journals
od 2006
Free Medical Journals
od 2006
Public Library of Science (PLoS)
od 2006
PubMed Central
od 2006
Europe PubMed Central
od 2006
ProQuest Central
od 2006-12-01
Open Access Digital Library
od 2006-10-01
Open Access Digital Library
od 2006-01-01
Open Access Digital Library
od 2006-01-01
Medline Complete (EBSCOhost)
od 2008-01-01
Nursing & Allied Health Database (ProQuest)
od 2006-12-01
Health & Medicine (ProQuest)
od 2006-12-01
Public Health Database (ProQuest)
od 2006-12-01
ROAD: Directory of Open Access Scholarly Resources
od 2006
- MeSH
- buněčné linie MeSH
- cytotoxiny metabolismus toxicita MeSH
- deoxyuridin analogy a deriváty metabolismus toxicita MeSH
- DNA biosyntéza genetika metabolismus MeSH
- inhibitory enzymů metabolismus toxicita MeSH
- intracelulární prostor účinky léků metabolismus MeSH
- lidé MeSH
- poškození DNA * MeSH
- proliferace buněk účinky léků MeSH
- replikace DNA účinky léků MeSH
- S fáze účinky léků MeSH
- tetrahydrofoláty biosyntéza MeSH
- thymidin metabolismus farmakologie MeSH
- thymidinmonofosfát metabolismus MeSH
- thymidylátsynthasa antagonisté a inhibitory MeSH
- vztah mezi dávkou a účinkem léčiva MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
2'-Deoxy-5-ethynyluridine (EdU) has been previously shown to be a cell poison whose toxicity depends on the particular cell line. The reason is not known. Our data indicates that different efficiency of EdU incorporation plays an important role. The EdU-mediated toxicity was elevated by the inhibition of 2'-deoxythymidine 5'-monophosphate synthesis. EdU incorporation resulted in abnormalities of the cell cycle including the slowdown of the S phase and a decrease in DNA synthesis. The slowdown but not the cessation of the first cell division after EdU administration was observed in all of the tested cell lines. In HeLa cells, a 10 μM EdU concentration led to the cell death in the 100% of cells probably due to the activation of an intra S phase checkpoint in the subsequent S phase. Our data also indicates that this EdU concentration induces interstrand DNA crosslinks in HeLa cells. We suppose that these crosslinks are the primary DNA damage resulting in cell death. According to our results, the EdU-mediated toxicity is further increased by the inhibition of thymidylate synthase by EdU itself at its higher concentrations.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc16010561
- 003
- CZ-PrNML
- 005
- 20180426204711.0
- 007
- ta
- 008
- 160408s2015 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1371/journal.pone.0117459 $2 doi
- 024 7_
- $a 10.1371/journal.pone.0117459 $2 doi
- 035 __
- $a (PubMed)25671308
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Ligasová, Anna $u Institute of Molecular and Translational Medicine, Faculty of Medicine, Palacký University, Olomouc, 779 00, Czech Republic.
- 245 12
- $a A fatal combination: a thymidylate synthase inhibitor with DNA damaging activity / $c A. Ligasová, D. Strunin, D. Friedecký, T. Adam, K. Koberna,
- 520 9_
- $a 2'-Deoxy-5-ethynyluridine (EdU) has been previously shown to be a cell poison whose toxicity depends on the particular cell line. The reason is not known. Our data indicates that different efficiency of EdU incorporation plays an important role. The EdU-mediated toxicity was elevated by the inhibition of 2'-deoxythymidine 5'-monophosphate synthesis. EdU incorporation resulted in abnormalities of the cell cycle including the slowdown of the S phase and a decrease in DNA synthesis. The slowdown but not the cessation of the first cell division after EdU administration was observed in all of the tested cell lines. In HeLa cells, a 10 μM EdU concentration led to the cell death in the 100% of cells probably due to the activation of an intra S phase checkpoint in the subsequent S phase. Our data also indicates that this EdU concentration induces interstrand DNA crosslinks in HeLa cells. We suppose that these crosslinks are the primary DNA damage resulting in cell death. According to our results, the EdU-mediated toxicity is further increased by the inhibition of thymidylate synthase by EdU itself at its higher concentrations.
- 650 _2
- $a buněčné linie $7 D002460
- 650 _2
- $a proliferace buněk $x účinky léků $7 D049109
- 650 _2
- $a cytotoxiny $x metabolismus $x toxicita $7 D003603
- 650 _2
- $a DNA $x biosyntéza $x genetika $x metabolismus $7 D004247
- 650 12
- $a poškození DNA $7 D004249
- 650 _2
- $a replikace DNA $x účinky léků $7 D004261
- 650 _2
- $a deoxyuridin $x analogy a deriváty $x metabolismus $x toxicita $7 D003857
- 650 _2
- $a vztah mezi dávkou a účinkem léčiva $7 D004305
- 650 _2
- $a inhibitory enzymů $x metabolismus $x toxicita $7 D004791
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a intracelulární prostor $x účinky léků $x metabolismus $7 D042541
- 650 _2
- $a S fáze $x účinky léků $7 D016196
- 650 _2
- $a tetrahydrofoláty $x biosyntéza $7 D013763
- 650 _2
- $a thymidin $x metabolismus $x farmakologie $7 D013936
- 650 _2
- $a thymidinmonofosfát $x metabolismus $7 D013938
- 650 _2
- $a thymidylátsynthasa $x antagonisté a inhibitory $7 D013940
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Strunin, Dmytro $u Institute of Molecular and Translational Medicine, Faculty of Medicine, Palacký University, Olomouc, 779 00, Czech Republic.
- 700 1_
- $a Friedecký, David $u Institute of Molecular and Translational Medicine, Faculty of Medicine, Palacký University, Olomouc, 779 00, Czech Republic.
- 700 1_
- $a Adam, Tomáš, $d 1965- $7 xx0054162 $u Institute of Molecular and Translational Medicine, Faculty of Medicine, Palacký University, Olomouc, 779 00, Czech Republic.
- 700 1_
- $a Koberna, Karel $u Institute of Molecular and Translational Medicine, Faculty of Medicine, Palacký University, Olomouc, 779 00, Czech Republic.
- 773 0_
- $w MED00180950 $t PloS one $x 1932-6203 $g Roč. 10, č. 2 (2015), s. e0117459
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/25671308 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20160408 $b ABA008
- 991 __
- $a 20180426204744 $b ABA008
- 999 __
- $a ok $b bmc $g 1113990 $s 934929
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2015 $b 10 $c 2 $d e0117459 $e 20150211 $i 1932-6203 $m PLoS One $n PLoS One $x MED00180950
- LZP __
- $a Pubmed-20160408